Experiences of continuous infusion of B-domain deleted recombinant factor VIII (ReFacto®) for major surgery.

被引：0
|
作者：
Schulman, S
Roussel-Robert, V
Stieltjes, N
Negrier, C
Reynaud, J
Villar, A
Pouzol, P
Savidge, GF
Altisent, C
Auerswald, G
机构：
[1] Karolinska Hosp, S-10401 Stockholm, Sweden
[2] Hop Cochin, F-75674 Paris, France
[3] Hop Edouard Herriot, Lyon, France
[4] Hop Nord St Etienne, St Etienne, France
[5] Hosp La Paz, Madrid, Spain
[6] Hop Robert Debre, Reims, France
[7] St Thomas Hosp, London, England
[8] Vall Hebron, Barcelona, Spain
[9] Zentralkrankenhaus St Jurgen Str, Bremen, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3920
引用
收藏
页码：111B / 111B
页数：1
相关论文
共 50 条
  • [1] Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery:: clinical experience
    Stieltjes, N
    Altisent, C
    Auerswald, G
    Négrier, C
    Pouzol, P
    Reynaud, J
    Roussel-Robert, V
    Savidge, GF
    Villar, A
    Schulman, S
    HAEMOPHILIA, 2004, 10 (05) : 452 - 458
  • [2] In vitro evaluation of B-domain deleted recombinant factor VIII (ReFacto®) stability during simulated continuous infusion administration
    Neidhardt, E
    Koval, R
    Burke, E
    Warne, N
    HAEMOPHILIA, 2005, 11 (04) : 319 - 325
  • [3] Measurement of factor VIII activity of B-domain deleted recombinant factor VIII
    Mikaelsson, M
    Oswaldsson, U
    Jankowski, MA
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 13 - 23
  • [4] B-domain deleted recombinant factor VIII formulation and stability
    Österberg, T
    Fatouros, A
    Neidhardt, E
    Warne, N
    Mikaelsson, M
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 40 - 43
  • [5] Second generation, B-domain deleted recombinant factor VIII
    Berntorp, E
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (01) : 256 - 260
  • [6] Viral safety of B-domain deleted recombinant factor VIII
    Charlebois, TS
    O'Connell, BD
    Adamson, SR
    Brink-Nilsson, H
    Jernberg, M
    Eriksson, B
    Kelley, BD
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 32 - 39
  • [7] The manufacturing process for B-domain deleted recombinant factor VIII
    Eriksson, RK
    Fenge, C
    Lindner-Olson, E
    Ljungqvist, C
    Rosenquist, J
    Smeds, AL
    Östlin, A
    Charlebois, T
    Leonard, M
    Kelley, BD
    Ljungqvist, Å
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 24 - 31
  • [8] Monitoring of factor VIII level in patients treated with B-domain deleted recombinant FVIII (ReFacto®).: A need for standardization.
    Toulon, PA
    Santos, MD
    BLOOD, 2002, 100 (11) : 698A - 698A
  • [9] B-domain deleted recombinant factor VIII for the treatment of hemophilia A - Introduction
    Berntorp, E
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 1 - 3
  • [10] Structural and functional characterization of B-domain deleted recombinant factor VIII
    Sandberg, H
    Almstedt, A
    Brandt, J
    Castro, VM
    Gray, E
    Holmquist, L
    Lewin, M
    Oswaldsson, U
    Mikaelsson, M
    Jankowski, MA
    Bond, M
    Scoble, HA
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 4 - 12
12345